Clinical Chemistry and Hematology Laboratories
Links
Related Links
- Blood Cells - Life's Blood
- Disease Carriers
Related sub-categories
- Featured Image Archive
- Microscopy Facilities
Related sub-categories (Links)
- 3-D Electron Microscopy
Sub-categories: Related Links
Clinical Chemistry: Blood pH and Gases
This program monitors the performance of approximately 300 participating laboratories for three analytes: pH, Pco2 and Po2. Cassettes containing five ampules of buffered material are submitted to the laboratories three times per year for analysis.
CATEGORY DESCRIPTION
Laboratories performing measurement of blood pH, Pco2, and/or Po2 should hold a permit in Blood pH and Gases.
SOURCE OF SAMPLES
For blood pH, Pco2, Po2 commercially prepared perfluorocarbon or aqueous based specimens are used.
QUALITY CONTROL OF SAMPLES
Samples are distributed at ambient temperature. Volunteer laboratories in remote locations (including central reference laboratories in the Federal Republic of Germany, and the People's Republic of China) participate as volunteers in our program and monitor stability in long distance shipments. Specimens returned from laboratories are assayed upon return. Accelerated lability studies (monitoring samples at 20oC and 37oC) are also conducted. Specimens are assayed within our laboratory for tested analytes from representative vials to assess sample-to-sample variability. Unlike lyophilized specimens, liquid specimens exhibit minimal sample-to-sample variability. Specimens are prepared under sterile conditions minimizing deterioration due to potential bacterial contamination.
SAMPLE VALIDATION
The following acceptable performance criteria are used for sample validation:
| ANALYTE | TARGET VALUE |
| Blood gas Po2 | ± 3 SD |
| Blood gas Pco2 | ± 5 mmHg or ± 8%(whichever is greater) |
| pH | ± 0.04 |
TARGET VALUES
Target values are calculated by the mean of all participant responses after removal of outliers (those responses > ±3 SD from the original mean). Where available, target values are established, or verified, by reference methods or weighed-in values. Comparative method or "peer group" targets are used when it is demonstrated that specific methods demonstrate a bias with a proficiency specimen that is not observed with patient specimens.
GRADING
Grading for Blood pH and Gases is performed as follows:
| Number of acceptable responses for the analyte x 100 | = Total Score |
|
Number of challenges for the analyte |
| Number of acceptable responses for all challenges x 100 | = Testing Event Score |
|
Total number of all challenges |
RESOLVING PROBLEMS
Technical, scientific, or administrative problems associated with testing in this specialty/subspecialty should be directed to the appropriate contact people listed above. The problem is identified as either a transcription, pre-analytical or analytical error. The results in question as well as previous data submitted by the laboratory and all participant data are reviewed. Based on current proficiency testing experiences, in many instances, the problem can be resolved in the initial telephone call or correspondence. However, should further action be required, the following is initiated:
1. Self-check specimens are forwarded for repeat analysis.
2. Thorough review of the participant laboratory's previous testing experiences and within laboratory quality control.
3. Arrange for interlaboratory comparisons using patient specimens or alternative testing fluids.
4. If the problem continues, suggest consulting instrument service representative and/or manufacturer for input.
Based on current proficiency testing experiences, in many instances the problem is resolved with self-check samples or corrective maintenance performed by laboratory staff or the service representative. If proficiency testing specimens are not evaluated, proficiency testing reports include the notice "Not Evaluated" on the computer-generated report to inform participants. Critiques distributed to participant laboratories will further detail the instruments, proficiency specimens, reagent kit(s), analyte(s) or other variables involved. A thorough investigation on the nature of the matrix-associated problem, specimen stability, or method non-specificity will be undertaken. Possible matrix sensitivities of materials used will be examined [cf. Rej, R., Jenny, R. W., and Bretaudiere, J.P., Quality control in clinical chemistry: characterization of reference materials Talanta 31, 851-862 (1984)]. Based on current proficiency testing experiences with the specimens prepared by our laboratories, such occurrences are uncommon.
